The North America deflazacort market is witnessing steady growth with increasing attention to the diagnosis and treatment of Duchenne muscular dystrophy and other conditions requiring corticosteroid therapy. Improved access to specialized healthcare, growing awareness of rare diseases, and advancements in treatment approaches are supporting regional demand. Continued investment in rare disease...